Wednesday 22 July 2020
14:30 – 16:00 SAST / CEST | 13:30 - 15:00 BST | 08:30-11:00 EDT
Overview of an Ongoing COVID-19 Vaccine Trial
Panel Discussion 1 - Pharma & CROs Perspectives:
Clinical Trials Pipelines: A shift in global forecasting and investment due to the unexpected COVID-19.
How this affects clinical studies coming to South Africa, from a Sponsor and Pharma perspective.
Panel Discussion 2 - The Changing Landscape & New Ethics Approaches In Clinical Trials
Panel Discussion 3 - COVID-19: Clinical Trial Continuity Of The Study Site:
Site strategies under the new normal.
Local public health care facilities: Johannesburg’s perspective on management of COVID-19.
Dr Clare L. Cutland, BSc., MBBCH, DCH, PhD (Wits)
Scientific Coordinator, African Leadership in Vaccinology Expertise (ALIVE), University of the Witwatersrand
Country Head - South Africa, Novartis
Dr Essack Mitha
Newtown Clinical Research Centre, MeDiNova Site
Dr Michelle Middle MB.ChB, M.Pharm.Med
South African Clinical Trials Consulting